Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis

Muscle and Nerve

Volumn 40, Issue 1, 2009, Pages 126-129

  Chahin, Nizar ^a   Sorenson, Eric J ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Amyotrophic lateral sclerosis; Creatine kinase; Hypertrophic fibers; Prognosis; Spinobulbar muscular atrophy

Indexed keywords

CREATINE KINASE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HUMAN; KENNEDY DISEASE; MALE; MOTOR NEURON DISEASE; MUSCLE BIOPSY; MUSCLE HYPERTROPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CREATINE KINASE; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISORDERS, ATROPHIC; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 67650240395     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21310     Document Type: Article

References (22)

1. Amato AA, Prior TW, Barohn RJ, Snyder P, Papp A, Mendell JR. Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology 1993;43:791-794. (Pubitemid 23121976)
2. Amrit AN, Anderson MS. Serum creatine phosphokinase in amyotrophic lateral sclerosis. Correlation with sex, duration, and skeletal muscle biopsy. Neurology 1974;24:834-837.
3. Amrit AN, Anderson MS. Myopathic changes in amyotrophic lateral sclerosis: pathologic analysis of muscle biopsy changes in 111 cases. Neurology 1974;24:477.
4. Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, Tanaka F, Tamakoshi A, Sobue G. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 2006;129:1446-1455. (Pubitemid 43999377)
5. Chahin N, Klein C, Mandrekar J, Sorenson E. Natural history of spinal-bulbar muscular atrophy. Neurology 2008;70:1967-1971.
6. Dalakas MC. Morphologic changes in the muscles of patients with postpoliomyelitis neuromuscular symptoms. Neurology 1988;38:99. (Pubitemid 18028101)
7. Felice KJ, North WA. Creatine kinase values in amyotrophic lateral sclerosis. J Neurol Sci 1998;160(suppl 1):S30-S32. (Pubitemid 28522514)
8. Finsterer J, Miltenberger G, Rauschka H, Janecke A. Novel C59T leader peptide mutation in the MPZ gene associated with late-onset, axonal, sensorimotor polyneuropathy. Eur J Neurol 2006;13:1149-1152. (Pubitemid 44434324)
9. Harrington TM, Cohen MD, Bartleson JD, Ginsburg WW. Elevation of creatine kinase in amyotrophic lateral sclerosis. Potential confusion with polymyositis. Arthritis Rheum 1983;26:201-205.
10. Gath I, Sjaastad O, Løken AC. Myopathic electromyographic changes correlated with histopathology in Wohlfart-Kugelberg-Welander disease. Neurology 1969;19:344.
11. Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Naskashima K, Kira J, Kaji R, Oka N, Sobue G. Study Group for Hereditary Neuropathy in Japan. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 2003;126:134-151.
12. Iłzecka J, Stelmasiak Z. Creatine kinase activity in amyotrophic lateral sclerosis patients. Neurol Sci 2003;24:286-287. (Pubitemid 37493189)
13. Lee JH, Shin JH, Park KP, Kim IJ, Kim CM, Lim JG, Choi YC, Kim DS. Phenotypic variability in Kennedy's disease: implication of the early diagnostic features. Acta Neurol Scand 2005;112:57-63. (Pubitemid 40827604)
14. Panitch HS, Franklin GM. Elevation of serum creatine phosphokinase in amyotrophic lateral sclerosis. Neurology 1972;22:964-966.
15. Parboosingh JS, Figlewicz DA, Krizus A, Meininger V, Azad NA, Newman DS, et al. Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology 1997;49:568-572. (Pubitemid 27368903)
16. Rudnik-Schöneborn S, Lützenrath S, Borkowska J, Karwanska A, Hausmanowa-Petrusewicz I, Zerres K. Analysis of creatine kinase activity in 504 patients with proximal spinal muscular atrophy types I-III from the point of view of progression and severity. Eur Neurol 1998;39:154-162. (Pubitemid 28154546)
17. Sinaki M, Mulder DW. Amyotrophic lateral sclerosis: relationship between serum creatine kinase level and patient survival. Arch Phys Med Rehabil 1986;67:169-171. (Pubitemid 16016321)
18. Sorenson EJ, Klein CJ. Elevated creatine kinase and transaminases in asymptomatic SBMA. Amyotroph Lateral Scler 2007;8:62-64. (Pubitemid 46322942)
19. Sorarù G, D'Ascenzo C, Polo A, Palmieri A, Baggio L, Vergani L, et al. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci 2008;264:100-105. (Pubitemid 350184080)
20. Stewart HG, Mackenzie IR, Eisen A, Brännström T, Marklund SL, Andersen PM. Clinicopathological phenotype of ALS with a novel G72C SOD1 gene mutation mimicking a myopathy. Muscle Nerve 2006;33:701-706.
21. Waring WP, Davidoff G, Werner R. Serum creatine kinase in the post-polio population. Am J Phys Med Rehabil 1989;68:86-90. (Pubitemid 19118424)
22. Yiu EM, Ravat S, Ryan MM, Shield LK, Smith LJ, Kornberg AJ. Adolescent spinal muscular atrophy with calf hypertrophy and a deletion in the SMN gene. Muscle Nerve 2008;38:930-932. (Pubitemid 351915332)